A phase II study of cetuximab in combination with external beam radiation followed by consolidation chemotherapy [comprising carboplatin, paclitaxel and cetuximab] for patients with locally advanced non-small cell lung cancer (NSCLC)

Trial Profile

A phase II study of cetuximab in combination with external beam radiation followed by consolidation chemotherapy [comprising carboplatin, paclitaxel and cetuximab] for patients with locally advanced non-small cell lung cancer (NSCLC)

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs Cetuximab (Primary) ; Carboplatin; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top